Tucker Kelly

Tucker Kelly

Director Financiero/CFO en XENON PHARMACEUTICALS INC. .

Fortuna: - $ al 31/05/2026

55 años
Health Technology
Finance
Commercial Services

Perfil

Thomas P.
Kelly
is currently Chief Financial Officer at Xenon Pharmaceuticals, Inc. since 2025.
Formerly, Chief Financial Officer at Deciphera Pharmaceuticals, Inc. from 2015 to 2019, Chief Financial Officer at AdvanDx, Inc. from 2012 to 2015, Chief Financial Officer at deCODE Genetics ehf from 2010 to 2011, Chief Financial Officer and SVP-Finance & Corporate Development at Critical Therapeutics, Inc. from 2007 to 2008, Principal at Canaccord Adams, Inc. from 2003 to 2007, Vice President-Life Sciences Investment Banking at Robertson Stephens, Inc. from 1998 to 2002, and Associate at Foley Hoag LLP from 1996 to 1998.
Education includes graduate studies at The University of Chicago Law School and undergraduate studies at Edmund A. Walsh School of Foreign Service.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
15/10/2025 0 ( -.--% ) - $ 31/05/2026

Cargos activos de Tucker Kelly

EmpresasCargoInicio
XENON PHARMACEUTICALS INC. Director Financiero/CFO 15/10/2025

Antiguos cargos conocidos de Tucker Kelly.

EmpresasCargoFin
Director Financiero/CFO 16/03/2015
Director Financiero/CFO 01/01/2011
Director Financiero/CFO 04/11/2008
Corporate Officer/Principal 01/08/2007
Corporate Officer/Principal 01/07/2002
Ver el detalle de la experiencia de Tucker Kelly.

Formación de Tucker Kelly.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

88

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Finance

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology